Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-6505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-6505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A line graph depicting cumulative incidence (%) over time in years, comparing two groups labeled Atorvastatin (solid line) and Placebo (dashed line). The plot shows incidence increasing over 3.5 years, with Atorvastatin group consistently lower than Placebo. Hazard ratio and p-value are indicated at the bottom right of the graph.*

FDA Label Image

Figure-02 (Figure 02)

A line graph showing cumulative hazard percentages over time (up to 5 years) comparing placebo and atorvastatin. The graph illustrates lower cumulative hazard for atorvastatin versus placebo across the follow-up period, with a hazard ratio (HR) of 0.63 (95% CI 0.48-0.83) and p=0.001, indicating statistical significance.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows subjects (%) experiencing the event (0 to 0.2). The 10 mg dose trend is shown with a dashed line, and the 80 mg dose with a solid line, with a hazard ratio (HR 0.78, 95% CI 0.69-0.89) and a p-value of 0.0002 noted.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement of atoms including the calcium ion complex typical for this active ingredient used in oral tablet form.*

FDA Label Image

Label Image (Lbl500906505)

The label for ATORVASTATIN CALCIUM 80 mg film-coated tablets from A-S Medication Solutions. It specifies the oral dosage form, package containing 30 tablets, and storage instructions to keep at 68 to 77 degrees Fahrenheit. The label includes the NDC number 50090-6505 and a QR code for package insert access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.